|
XenaCare Holdings, Incorporation - Comparative Business Analysis Snapshot
Business Description
XenaCare Holdings, Incorporation. The Group's principal activity is to market and distribute clinical, life style performance and nutrition supplement products (NSPs). Its clinical NSP products include formulation and brand building of a line of NSPs for the replenishment of nutrients lost due to pharmaceutical medications, Lifestyles performance NSP products include formulation of a line of NSPs for the energy/lifestyle performance market to be sold through mass media buys, web sales and other channels of distribution and Protective NSP product in directed to the energy/lifestyle performance market. The Group's initial product, Sun Pill, is formulated to protect the skin when exposed to damaging ultraviolet rays. It operates in the United States.
Competitor Analysis
This analysis compares XenaCare Holdings, Incorporation with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
